Literature DB >> 16422800

Phosphodiesterase 5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NAION): coincidence or causality?

Dimitris Hatzichristou1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16422800     DOI： 10.1111/j.1743-6109.2005.00144.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN： 1743-6095            Impact factor:   3.802


× No keyword cloud information.
  6 in total

1.  NAION and treatment of erectile dysfunction: reply from Pfizer.

Authors:  R E Sobel; J C Cappelleri
Journal:  Br J Ophthalmol       Date:  2006-07       Impact factor: 4.638

Review 2.  Looking to the future for erectile dysfunction therapies.

Authors:  Konstantinos Hatzimouratidis; Dimitrios G Hatzichristou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?

Authors:  Konstantinos Hatzimouratidis
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 3.092

Review 4.  Future prospects in the treatment of erectile dysfunction: focus on avanafil.

Authors:  Amjad Alwaal; Raed Al-Mannie; Serge Carrier
Journal:  Drug Des Devel Ther       Date:  2011-10-18       Impact factor: 4.162

Review 5.  Microvascular complications in diabetic erectile dysfunction: do we need other alternatives?

Authors:  Yoram Vardi
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

Review 6.  Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Konstantinos Hatzimouratidis
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.